Cinepazide Maleate26328-04-1 top quality and Factory direct sales CAS NO.26328-04-1

4. Best service after shipment with email;

5. High quality & competitive price;

Cinepazide Maleate

CAS: 26328-04-1

English name Cinepazide maleate

Alias: 1-[(1-Pyrrolidinylcarbonyl) methyl]-4-(3,4,5-trimethoxycinnamoyl) piperazine maleate

Name: Cinepazide Maleate; 1-[(1-pyrrolidine formyl) methyl]-4-(3,4,5-trimethoxycinnamoyl) piperazine maleate

Appearance: White crystalline powder

Content: > 99%

Molecular structure:

Molecular weight: 533.57

Melting point: 170 ~175 C

PH: 3.0-4.0

Drying Weightlessness: <0.5%

Heavy metals: <10 ppm

Packaging: 1kg/listen

Molecular formula: C22H31N3O5.C4H4O4

Molecular weight: 533.57

Usage 1. Cerebrovascular diseases: cerebral arteriosclerosis, transient cerebral ischemia, cerebral thrombosis, cerebral embolism, cerebral hemorrhage and sequelae of brain trauma. 2. Cardiovascular diseases, for atherosclerosis, angina pectoris, patients with myocardial infarction should cooperate with the relevant drug treatment. 3. Fundus vascular diseases, cochlear vestibular dysfunction caused by ischemia, sudden deafness and tinnitus. 4. Microcirculation disturbance caused by diabetes mellitus (diabetic foot, diabetic retinopathy, etc.). 5. Other peripheral vascular diseases: thromboangiitis obliterans, arteritis, Reynolds disease, lower extremity atherosclerosis, etc.

Chinese Name Cinepazide Maleate

The English name Cinepazide Maleate

Chinese alias 1-[(1-pyrrolidine formyl) methyl]-4-(3,4,5-trimethoxycinnamoyl) piperazine maleate

CAS RN 26328-04-1

EINECS 247-613-1

Molecular formula C26H33N3O9

Molecular weight 531.556

English name: Cinepazide maleate

Chemical name: 1-[(1-pyrrolidine formyl) methyl]-4-(3,4,5-trimethoxycinnamoyl) piperazine maleate

1-[(1-Pyrrolidinylcarbonyl) methyl]-4-(3,4,5-trimethoxycinnamoyl) piperazine maleate

Molecular formula: C22H31N3O5. C4H4O4

Molecular weight: 533.58

CAS No. 26328-04-1

Appearance: White crystalline powder

Melting Point: 173-174 degrees C

Content: > 99%

Purpose: Cerebral vascular disease, cerebral arteriosclerosis, transient ischemic attack, cerebral thrombosis, cerebral embolism, post-operative recovery period of brain injury, sequelae of cerebral hemorrhage and sequelae of brain injury; Cardiovascular disease for coronary heart disease, angina pectoris, such as myocardial infarction, should be combined with relevant drugs; Atherosclerosis, thromboangiitis obliterans, arteritis, Reynolds disease; ophthalmology, otorhinolaryngology diseases, fundus vascular sclerosis, obstruction, ischemia caused by eye diseases, ischemia caused by cochlear vestibular dysfunction, sudden deafness, tinnitus, etc; diabetes caused by peripheral vascular lesions and microcirculation disorders